ArticleBMC health services research2025
Patient and program level correlates of 30-day readmissions: a retrospective analysis of a transitional care program.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHospital readmissions present a substantial burden to patients and healthcare systems in terms of outcomes and financial penalties. The primary purpose of this study was to identify patient and program-specific factors linked to 30-day readmissions in patients with congestive health failure (CHF) enrolled in a hospital-based transitional care program.
methodsWe performed a retrospective analysis of electronic health record (EHR) data and program records from 343 community-dwelling adults (median age 81, 50.4% female, 67.9% White, 21% Black) with congestive heart failure (CHF) who were discharged from a community hospital in Westchester County, NY between January 1, 2023 and December 31, 2023. Our outcome of interest was 30-day hospital readmission. Logistic regression models were used to examine patient and program-specific predictors of 30-day readmission.
resultsOf 343 individuals, 19.8% were readmitted within 30 days. Each point increase in comorbidities was associated with 52% greater odds of readmission (p < 0.001, CI 1.24, 1.85). Those with ambulatory follow-up within 7 days had 63% lower odds of 30-day readmission compared to those without 7-day follow-up (p = 0.002, CI 0.2, 0.69). Those who interacted with the Transitional Care Management (TCM) team had an 84% lower risk of readmission compared to those who were not reached by the team.
conclusionComprehensive transitional care programs have potential to reduce the risk of unnecessary hospital readmissions in patients with CHF. Touch points are key for patients discharged from the hospital following a CHF admission, whether via a transitional care program, ambulatory providers, or (ideally) both regardless of how soon after discharge this occurs. CLINICAL TRIAL NUMBER: Not applicable
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.